The activation of ERK1/2 (Figure 6) and Src [46] in response to CTS in cancer cells indicates that the Src/Ras/MAPK signaling pathways may play a role in protecting tumor cells from apoptosis. This evidence concerns the gene MAPK3 and neoplasm.